Answers are grounded in this paper and cite their sources.
A blood-based biomarker panel in combination with PLCOm2012 significantly improves lung cancer risk assessment for lung cancer screening.
No takes yet. Share an insight, caveat, or question.
Fahrmann et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: